Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7797181 | 1.00 | KMT2A (0.62) | KMT2AMEN1GAACES2NPSR1 | |
| SCHEMBL30112938 | 1.00 | KMT2A (0.62) | KMT2AMEN1GAACES2NPSR1 | |
| SCHEMBL15295774 | 1.00 | KMT2A (0.62) | KMT2AMEN1GAACES2NPSR1 | |
| SCHEMBL17899795 | 0.85 | KMT2A (0.62) | KMT2AMEN1GAACES2NPSR1 | |
| SCHEMBL7255041 | 0.84 | KMT2A (0.60) | KMT2AMEN1GAACES2NPSR1 | |
| SCHEMBL15597554 | 0.84 | MEN1 (0.45) | KMT2AMEN1GAACES2NPSR1 | |
| SCHEMBL7255042 | 0.84 | KMT2A (0.60) | KMT2AMEN1GAACES2NPSR1 | |
| Trifluoromethylbenzene SCHEMBL28068069 | 0.83 | ALDH1A1 (0.54) | KMT2AMEN1GAACES2ALDH1A1 | |
| SCHEMBL8274363 | 0.83 | ACHE (0.51) | KMT2AMEN1GAANPSR1HTT | |
| SCHEMBL14088920 | 0.83 | ACHE (0.51) | KMT2AMEN1GAANPSR1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040314-A | Method for continuously preparing m-trifluoromethyl acetophenone oxime | 山东师范大学实验厂有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-116589379-B | Post-treatment process of m-trifluoromethyl acetophenone oxime | 河北诚信集团有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119431183-A | Process for continuously synthesizing m-trifluoromethyl acetophenone oxime by adopting microchannel reactor | 中国计量大学 | 2025-02-14 | — | — | CN | claimed |
| CN-118993932-A | Efficient clean synthesis method of m-trifluoromethyl acetophenone oxime | 辽宁众辉生物科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-115043754-B | Clean synthesis method of trifloxystrobin | 辽宁众辉生物科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| EP-3681863-B1 | \"AN IMPROVED PROCESS FOR THE PREPARATION OF TRIFLOXYSTROBIN\ | HIKAL LTD (IN) | 2024-07-17 | — | — | EP | claimed |
| CN-117886715-A | Green and efficient synthesis method of m-trifluoromethyl acetophenone oxime | 山东京博农化科技股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117820163-A | Synthesis method of trifloxystrobin | 山东华阳农药化工集团有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-114685313-B | Preparation method of trifloxystrobin | 江西天宇化工有限公司 | 2024-04-05 | — | — | CN | claimed |
| WO-2023223105-A1 | A PROCESS OF PREPARATION OF 3'-(TRIFLUOROMETHYL)ACETOPHENONE (TFMAP) | DEEPAK NITRITE LIMITED (IN) | 2023-11-23 | — | — | WO | claimed |
| CN-112538029-A | Green synthesis method for preparing trifloxystrobin with high yield | 利民化学有限责任公司 | 2021-03-23 | — | — | CN | claimed |
| US-20200283373-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF TRIFLOXYSTROBIN | HIKAL LIMITED (IN) | 2020-09-10 | — | — | US | claimed |
| CN-111333535-A | Preparation method of trifloxystrobin | 江苏食品药品职业技术学院 | 2020-06-26 | — | — | CN | claimed |
| CN-101941921-A | Method for preparing trifloxystrobin | YUEYANG DIPU CHEMICAL TECHNOLOGY CO LTD | 2011-01-12 | — | — | CN | claimed |
| CN-100357263-C | Preparation process of oxime strain ester | UNIV TONGJI (CN) | 2007-12-26 | — | — | CN | claimed |
| CN-100334070-C | Tech. for synthesizing high productivity oxime kresoxim | TONGNA ENVIRONMENT PROT SCI & (CN) | 2007-08-29 | — | — | CN | claimed |
| CN-1303061-C | Liquid phase synthesis process of oxime strain ester by poly-ethandiol | UNIV TONGJI (CN) | 2007-03-07 | — | — | CN | claimed |
| CN-1793115-A | Tech. for synthesizing high productivity oxime kresoxim | TONGNA ENVIRONMENT PROT SCI & (CN) | 2006-06-28 | — | — | CN | claimed |
| CN-1560028-A | Liquid phase synthesis process of oxime strain ester by poly-ethandiol | 同济大学 | 2005-01-05 | — | — | CN | claimed |
| CN-1560027-A | Preparation process of oxime strain ester | 同济大学 | 2005-01-05 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283373-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF TRIFLOXYSTROBIN | SI, TREH, CYP3A7 | KMT2A 3996/4885MEN1 2691/4885GAA 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.